EUVIMEDEUVIMED entdecken
Crossref

STING‐Activating Polymers Boost Lymphatic Delivery of mRNA Vaccine to Potentiate Cancer Immunotherapy

Miao Zhang, Yongling Wang, Benhao Li, Bowei Yang, Mengyao Zhao, Bingyu Li, Jianping Liu, Yaxin Hu, Zhaoming Wu, Yenhui Ong, Xiaolin Han, Lingwen Ding und 8 weitere

Advanced Materials · 2025

DOI: 10.1002/adma.202412654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Miao Zhang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore. Hauptthemen laut MEDLINE: Immunotherapy, Polymers, Cancer Vaccines, Membrane Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: National University of Singapore, National Medical Research Council, Singapore Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The unprecedented success of mRNA vaccines against COVID‐19 has inspired scientists to develop mRNA vaccines for cancer immunotherapy. However, using nucleoside modified mRNA as vaccine, though evading innate immune toxicity, diminishes its therapeutic efficacy for cancers. Here, we report a polyvalent stimulator of interferon genes (STING) activating polymer (termed as PD) to bolster the immunogenicity of mRNA vaccine. PD is made of tertiary amine units and conjugated with a biodegradable alkyl chain. Co‐formulation of PDs bearing different number of tertiary amines with lipid materials and mRNA resulted in the lipid‐like nanoparticles (PD LNPs) which effectively promoted lymphatic delivery and elicited robust immune activation via the STING signaling pathway. Notably, PD with eighteen tertiary amines (PD18) is predominant in balancing immune activity and tolerability. Subcutaneous administration of PD18 LNPs containing ovalbumin (OVA) mRNA enhanced the frequency of antigen specific CD8 + T cell with immune memory, leading to potent anticancer efficacy that surpassed 2′3’‐cGAMP in both prophylactic and therapeutic cancer models. Additionally, PD18 LNP‐based mRNA vaccine showed conferred resistance to cancer challenge for up to 60 days. Overall, this study offers a new perspective of using STING‐ activating polymer for imparting synergistic activity in mRNA vaccine‐based cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyPolymersCancer VaccinesMembrane ProteinsmRNA VaccinesRNA, MessengerNeoplasmsAnimalsMiceFemaleNanoparticlesHumansCell Line, TumorMice, Inbred C57BLCD8-Positive T-LymphocytesOvalbumin

Stichwörter der Autor:innen

STING activationcancer vaccinelipid nanoparticlemRNA deliverypolymer

Substanzen

PolymersCancer VaccinesMembrane ProteinsmRNA VaccinesRNA, MessengerOvalbumin

Autor:innen und Institutionen

  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
  • Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
  • Department of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi, 563003, P. R. China.
  • Department of Biological Science, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117558, Singapore.
  • Centre Interdisciplinaire de Nanoscience de Marseille, Aix-Marseille Universite, CNRS, UMR 7325, ́ "Equipe Labellisee Ligue ́Contre le Cancer", Marseille, 13288, France.
  • Department of Medical Imaging, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, 210002, China.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National University of Singapore
  • National Medical Research Council
  • Singapore Ministry of Education
  • National Research Foundation

Zitieren

APA

Zhang, M., Wang, Y., Li, B., Yang, B., Zhao, M., Li, B., Liu, J., Hu, Y., Wu, Z., Ong, Y., Han, X., Ding, L., Zhu, K., Li, J., Luo, M., Chen, S., Peng, L., Zhang, L., Chen, X., & Ni, Q. (2025). STING‐Activating Polymers Boost Lymphatic Delivery of mRNA Vaccine to Potentiate Cancer Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202412654

Vancouver

Zhang M, Wang Y, Li B, Yang B, Zhao M, Li B, et al. STING‐Activating Polymers Boost Lymphatic Delivery of mRNA Vaccine to Potentiate Cancer Immunotherapy. Advanced Materials. 2025. doi:10.1002/adma.202412654

BibTeX
@article{Zhang2025,
  author = {Zhang, Miao and Wang, Yongling and Li, Benhao and Yang, Bowei and Zhao, Mengyao and Li, Bingyu and Liu, Jianping and Hu, Yaxin and Wu, Zhaoming and Ong, Yenhui and Han, Xiaolin and Ding, Lingwen and Zhu, Kongfu and Li, Jianwei and Luo, Min and Chen, Shengqi and Peng, Ling and Zhang, Longjiang and Chen, Xiaoyuan and Ni, Qianqian},
  title = {STING‐Activating Polymers Boost Lymphatic Delivery of mRNA Vaccine to Potentiate Cancer Immunotherapy},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202412654}
}
Kostenlos starten →